Free Shipping on purchases over €100

Gema Herrerías 25 Peptides-Th Serum 30 ml

Serum with peptides by Gema Herrerías that combines firming and anti-wrinkle benefits for firmer and more elastic skin. With a high moisturising power thanks to its three types of hyaluronic acid. Suitable for all skin types.

Contains 30 ml.

SKU: GE8437019231460
-31%
29.70
€42.90
€99.00
/100ml

Pharmaceutical Care

Safe medication sales

Secure shipping

PHARMACEUTICAL RECOMMENDATION

License Number: 7270

Silvia Del Río

A pharmacist specializing in dermocosmetics, skin microbiota, and hygiene will advise and help you with the most suitable treatment.

Ask me

The perfect combo in an anti-ageing routine is to combine active ingredients that protect the skin in the morning (anti-oxidants such as vitamin C) with active ingredients that optimise the skin at night (peptides, which provide firmness and elasticity). In this way, we achieve firm, repulped and juicy skin.

0 products in total

INFO AND TECHNICAL SPECIFICATIONS

GH 25 Péptidos-Th is an intensive multi-peptide anti-ageing serum by Gema Herrerías, designed for the face and neck. Its exclusive formula combines firming properties that increase the elasticity and density of the skin, as well as a high moisturising power thanks to its content of three types of hyaluronic acid.
Developed for all types of mature skin with flaccidity and wrinkles, it contains 0.3% of three types of hyaluronic acid (HA): high molecular weight HA with moisturising properties, firming hydrolysed HA and acetylated HA with anti-wrinkle, antioxidant, anti-pollution and skin roughness reducing properties.
The result of the 25 Peptide-Th serum: deeply hydrated, elastic, firm skin with fewer wrinkles.
Formulated at pH ~ 5.3.7.
Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.